Novartis CEO says it won't join weight-loss drug frenzy

The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…

Eli Lilly to increase production of weight loss, diabetes and Alzheimer's drugs

A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…